Prostate cancer: Contemporary aDt usage reflects established benefit

Comment

Sarah Payton. Nat Rev Urol. 2010 Dec.

. 2010 Dec;7(12):644.

doi: 10.1038/nrurol.2010.194.

No abstract available

Comment on

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.
Bolla M, Van Tienhoven G, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Billiet I, Torecilla JL, Pfeffer R, Cutajar CL, Van der Kwast T, Collette L. Bolla M, et al. Lancet Oncol. 2010 Nov;11(11):1066-73. doi: 10.1016/S1470-2045(10)70223-0. Epub 2010 Oct 7. Lancet Oncol. 2010. PMID: 20933466 Clinical Trial.
Reimbursement policy and androgen-deprivation therapy for prostate cancer.
Shahinian VB, Kuo YF, Gilbert SM. Shahinian VB, et al. N Engl J Med. 2010 Nov 4;363(19):1822-32. doi: 10.1056/NEJMsa0910784. N Engl J Med. 2010. PMID: 21047226